why choose us

First received: March 23, 2024

Clinical Trial: Memantine Hydrochloride for Treatment of Cognitive Dysfunction Due to Traumatic Brain Injury

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Treatment of Cognitive Deficits After Traumatic Brain Injury

Study Type: INTERVENTIONAL


Official Title: Treatment of Post-traumatic Cognitive Dysfunction With Memantine Hydrochloride, an N-methyl-D-aspartate (NMDA)-Type Receptor Blocker: a Clinical Trial

Brief Summary: Posttraumatic consequences are common causes of disability and long-term morbidity.They include cognitive dysfunction, seizures, headache, dizziness, fatigue, sensory deficits, neurodegeneration and psychiatric disorders (e.g.posttraumatic stress disorder, depression, anxiety, etc).Diffuse axonal injury and disruption of normal neuronal function are the most common and important pathologic features of traumatic primary closed head injury.depression, anxiety, etc).Excitotoxicity and apoptosis caused by activation…

Read more